検索結果

临床试验信息 | 研究与开发 | 千寿制药株式会社

-0008 Japan Completed jRCT2031210444 Healthy Volunteers 1 SJP-0008 Japan Completed jRCT2031210280 Disclaimer This website provides information on clinical trials sponsored by SENJU PHARMACEUTICAL Co.,...

that “Avarept® Ophthalmic Suspension 0.3%” (Generic Name: Motugivatrep; hereinafter: Avarept® ), discovered and licensed from Mochida Pharmaceutical Co., Ltd. (Headquarters: Tokyo, Japan; President: ...

Compliance System | Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical

the cooperation of medical establishments and be fully mindful of respecting the human rights and discretion of the trial subjects, protecting personal information meticulously and ensuring safety. We...

試験). 1979. 53) Goldenthal. E. I.：社内資料 (ラットにおける 24 カ月がん原性試験), 1979 54) Tanaka, N. et al.：J. Toxicol. Sci. 1979; 4: 47-58. (PMID: 480405) 55) 田中暢幸ほか：応用薬理. 1976; 11(2): 211-219. 56) Tamagawa, M. et al.：J...

that “Avarept® Ophthalmic Suspension 0.3%” (Generic Name: Motugivatrep; hereinafter: Avarept® ), discovered and licensed from Mochida Pharmaceutical Co., Ltd. (Headquarters: Tokyo, Japan; President: ...